FCMI
Foresite Capital Management III’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,954,904
| Closed | -$35.2M | – | 5 |
|
|
2021
Q3 | $35.2M | Hold |
1,954,904
| – | – | 48.8% | 1 |
|
|
2021
Q2 | $34.3M | Hold |
1,954,904
| – | – | 36.39% | 1 |
|
|
2021
Q1 | $49.3M | Buy |
1,954,904
+334,660
| +21% | +$8.43M | 43.26% | 1 |
|
|
2020
Q4 | $10.5M | Buy |
1,620,244
+935,332
| +137% | +$6.05M | 12.18% | 6 |
|
|
2020
Q3 | $1.76M | Buy |
+684,912
| New | +$1.76M | 1.31% | 9 |
|
|
2019
Q1 | – | Sell |
-265,694
| Closed | -$1.96M | – | 20 |
|
|
2018
Q4 | $1.96M | Sell |
265,694
-46,674
| -15% | -$345K | 0.64% | 22 |
|
|
2018
Q3 | $4.54M | Hold |
312,368
| – | – | 1% | 18 |
|
|
2018
Q2 | $6.24M | Hold |
312,368
| – | – | 1.34% | 16 |
|
|
2018
Q1 | $5.47M | Buy |
312,368
+99,418
| +47% | +$1.74M | 1.19% | 15 |
|
|
2017
Q4 | $5.25M | Sell |
212,950
-50,000
| -19% | -$1.23M | 1.47% | 14 |
|
|
2017
Q3 | $6.79M | Buy |
+262,950
| New | +$6.79M | 1.87% | 13 |
|
|
2017
Q2 | – | Sell |
-140,000
| Closed | -$4.18M | – | 27 |
|
|
2017
Q1 | $4.18M | Sell |
140,000
-15,767
| -10% | -$470K | 1.6% | 14 |
|
|
2016
Q4 | $4.23M | Buy |
+155,767
| New | +$4.23M | 1.84% | 13 |
|